Hotline:
+ 49 (0) 2204 2918806
Life Sciences
Biological science comprises the whole spectrum of medical research. It includes pharmacy, health care, medical devices and diagnostics. Due to its many direct and indirect impacts, an increased focus has shifted to biotechnology during the last couple of years. Many biotech companies have developed into pharmaceutical and bio-pharmaceutical giants. The biological branch plays an important role for the majority of our society and therefore proved to be an area of particular commercial success. This also explains the strong interest in information potentially providing a strategic market advantage. This category offers diverse information on topics such as digital radiography, laboratory diagnostics, haematology, oncology etc.
Subscribe to RSS Feed

Market studies for category Life Sciences

Items 1 to 10 of 1940 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 194
  1. Net price*
    Year
  2. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Streptococcus Pneumoniae Infection – Pipeline Review, H1 2013

    Global Markets Direct
    48 pages
    Introduction Global Markets Direct’s, 'Streptococcus Pneumoniae Infection - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Streptococcus Pneumoniae Infection, complete with latest updates, and special features on late-stage a
    Englisch | Report | SKU: 329732
  3. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Pancreatic Ductal Adenocarcinoma - Pipeline Review, H1 2013

    Global Markets Direct
    44 pages
    Global Markets Direct’s, 'Pancreatic Ductal Adenocarcinoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Pancreatic Ductal Adenocarcinoma, complete with latest updates, and special features on late-stage and discontinued p
    Englisch | Zukunftsanalyse | SKU: 344501
  4. $4,995.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    PharmaPoint: Microvascular Complications of Diabetes - Japan Drug Forecast and Market Analysis to 2022

    GlobalData
    145 pages
    The entire market for microvascular complications of diabetes (MCD) – diabetic nephropathy, retinopathy, and neuropathy – is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsely populated pipeline. The diabetic
    Englisch | Zukunftsanalyse | SKU: 389013
  5. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Amyloidosis – Pipeline Review, H1 2013

    Global Markets Direct
    90 pages
    Introduction Global Markets Direct’s, 'Amyloidosis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Amyloidosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key
    Englisch | Report | SKU: 318838
  6. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2012

    GlobalData
    94 pages
    Introduction GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2012” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provides detailed information
    Englisch | Report | SKU: 330416
  7. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Collegium Pharmaceutical, Inc. - Product Pipeline Review - 2013

    Global Markets Direct
    31 pages
    Global Market Direct’s pharmaceuticals report, “Collegium Pharmaceutical, Inc. - Product Pipeline Review - 2013” provides data on the Collegium Pharmaceutical, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dor
    Englisch | Zukunftsanalyse | SKU: 386336
  8. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Genital Warts (Condylomata Acuminata) – Pipeline Review, H1 2013

    Global Markets Direct
    52 pages
    Introduction Global Markets Direct’s, 'Genital Warts (Condylomata Acuminata) - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Genital Warts (Condylomata Acuminata), complete with latest updates, and special features on late-s
    Englisch | Report | SKU: 329796
  9. $4,779.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Pass Mark for ICT - The UK schools ICT market forecast to 2017-18

    Kable Global ICT Intelligence
    63 pages
    Product SynopsisThis report tracks central government ICT decision maker trends. It is intended both for those currently working with public sector clients, and those considering this market for the first time.Introduction and LandscapeSchools in the UK spent £1.36bn on ICT in 2012/13, and this will grow at a CAGR of just 0.4% over the n
    Englisch | Industry Forecast Report | SKU: 378358
  10. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Deep Vein Thrombosis (DVT) – Pipeline Review, H1 2013

    Global Markets Direct
    68 pages
    Introduction Global Markets Direct’s, 'Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Deep Vein Thrombosis (DVT), complete with latest updates, and special features on late-stage and discontinued
    Englisch | Report | SKU: 324408
  11. $495.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    ICT Spend Predictions in Large Dutch Healthcare Providers - Estimated ICT budget breakdowns in 2013

    Kable Global ICT Intelligence
    19 pages
    SynopsisThis report illustrates how Kable expects Large Dutch Healthcare Providers to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.SummaryWhy was the report written?This report presents the output from Kable's ICT spend prediction statis
    Englisch | Databook | SKU: 330825

Items 1 to 10 of 1940 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 194